Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Vaccine development is proceeding at an unprecedented pace, but could still hit snags on the way to approval.
New mRNA vaccine approach protects monkeys from HIV-like virus.
A small, secret panel of experts have been tasked with reviewing crucial data of coronavirus vaccines that U.S. taxpayers have helped fund.
The trial is evaluating an investigational vaccine from Janssen that may require only one shot.
An estimated 60% of Republicans and 46% of Democrats say they wouldn’t get inoculated if a vaccine was available.
FDA weighs whether to resume coronavirus vaccine trial halted due to an adverse event.
A U.K. woman developed spinal inflammation after receiving an adenovirus vector vaccine.
Public health departments are now being told to prepare to distribute COVID-19 vaccines as early as November 1.
More diversity would help doctors determine whether coronavirus treatments and vaccines will work for all population groups.
To not include the 1.2 million people with HIV in the United States is dangerous and irresponsible
Advocates claim victory after more than 1,000 people endorse a demand for inclusion.
Four vaccine candidates produced antibody and T-cell immune responses in the first stages of human clinical trials.
HIV advocates discuss how lessons from pandemic vaccine development can help fight COVID-19.
The finding could eventually be used to make an HIV vaccine prompt a longer-lasting immune response in humans.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.